Featured
Case Studies
Cardiovascular disease and adherence to guidelines
In recent years, advances in medical technology, knowledge, and new drugs have helped to improve outcomes in cardiovascular disease (CVD) – but nevertheless it remains a leading cause of death and serious illness.1,2 CVD is the number one cause...
Press Releases
New Analysis Shows Repatha Reduces Cardiovascular Events In Patients With History Of Stroke
Amgen announced that a new analysis showed lowering low-density lipoprotein cholesterol (LDL-C) levels with Repatha® (evolocumab) reduced the risk of cardiovascular events in a sub-group of patients with a history of stroke from the Repatha cardiovascular outcomes study (FOURIER)....
Industry Reports
Merck to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities
Merck, a leading science and technology company, today announced that it has entered into an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography. The transaction is expected to close in Q3...
Research Insight
The University of Virginia Health System and Premier Inc Create Strategic Partnership
The University of Virginia Health System (UVA), a 600-bed academic medical center serving the Commonwealth, Mid-Atlantic and beyond, has signed a multi-year agreement with Premier Inc. a leading healthcare improvement company, to access total cost and quality management services,...
Industry Reports
Philips completes acquisition of The Spectranetics Corporation
Royal Philips , a global leader in health technology announced that it has completed the acquisition of The Spectranetics Corporation , a U.S.-based global leader in vascular intervention and lead management solutions. Spectranetics’ financial results will be consolidated as...
Industry Reports
TriNetX Announces Availability of OMOP Common Data Model Toolkit for Data Acquisition
TriNetX, the global health research network for healthcare organizations, biopharma, and contract research organizations (CROs), announced support for the Observational Medical Outcomes Partnership (OMOP) common data model. Combined with its support of i2b2 database sites, the addition of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read